(9 years, 10 months ago)
Commons ChamberYes, I can absolutely confirm that, and I thank my hon. Friend for raising the point. It is important to say that this is not an exact science, because we do not know everything about the disease, so a balance sometimes has to be struck, but I think my discussions with Professor Paul Cosford and the chief medical officer have brought us to the right place: we follow the clear clinical guidelines, but where there is a precautionary extra step we think would be sensible in the circumstances, we take that as well.
I place on record my thanks for the work done by Pauline Cafferkey and her colleagues and express my sympathy for the predicament in which she finds herself. I would like to thank the Secretary of State, too, for what he said about continuing to keep screening arrangements under review and looking to improve them on the basis of expert clinical advice. If recommendations emerge quickly for improvements to, or an expansion of, screening, will he move equally quickly to put those recommendations into place?
(12 years, 8 months ago)
Commons ChamberLet me just say this to the hon. Member for Barnsley East (Michael Dugher), who is sitting on the Opposition Front Bench. There may be many things that we can debate in this House, including the policies, but I deeply resent any implication that I do not care about the national health service. I believe that I have demonstrated that I do; and his hon. Friends—and, to be fair, the right hon. Member for Leigh—have made that absolutely clear, time and again. Dr Clare Gerada, on behalf of the Royal College of General Practitioners, has said clearly that she recognises the Prime Minister’s and my passion and commitment and that of the Prime Minister to support the national health service.
The Secretary of State said some moments ago that the Bill had all been debated in this House, but of course it has not. Possibly the most damaging aspect financially to the NHS outside England is the increase in usage of the private sector in the NHS in England to 49%. That has never been debated in this House, has it?
I am afraid that the hon. Gentleman is completely wrong. The private income cap for foundation trusts was debated fully in Committee in this House, and it has been debated again in another place. The reason for the so-called 49% was simply that Members in another House said that they wanted to be absolutely clear that the principal legal purpose of foundation trusts is to provide services to the NHS, and therefore that, by definition, a foundation trust could not have more of its activity securing private income than NHS income, hence the 49%. But in truth, the safeguards that are built in make it absolutely clear that, whatever the circumstances and whatever their private income might be—from overseas activities or overseas patients coming to this country—foundation trusts must always demonstrate that they are benefiting NHS patients. That is why, I remind the House again, the foundation trust with the highest private income—27%—is the Royal Marsden, which delivers consistently excellent care for NHS patients.